Polen Capital Management
TECH icon

Polen Capital Management’s Bio-Techne TECH Stock Holding History

Polen Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-46,314
Closed -$2.72M – 265
2025
Q1 		$2.72M Buy
46,314
+25,554
+123% +$1.73M 0.01% 76
2024
Q4 		$1.5M Sell
20,760
-6,683
-24% -$491K ﹤0.01% 93
2024
Q3 		$2.19M Sell
27,443
-8,014
-23% -$602K 0.01% 85
2024
Q2 		$2.54M Sell
35,457
-1,567
-4% -$115K 0.01% 76
2024
Q1 		$2.61M Buy
37,024
+14,641
+65% +$1.05M 0.01% 83
2023
Q4 		$1.73M Buy
+22,383
New +$1.47M ﹤0.01% 100

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Polen Capital Management's TECH Position: Q2 2025 in Review

Polen Capital Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 46,314 shares — an estimated $2.72M sold.

Polen Capital Management first reported a position in TECH in Q4 2023 and held it in 6 quarters. The position peaked at $2.72M in Q1 2025. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Polen Capital Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • Polen Capital Management sold 46,314 Bio-Techne shares in Q2 2025, an estimated $2.72M.
  • Polen Capital Management first reported a position in Bio-Techne in Q4 2023 and held it in 6 quarters.
  • Polen Capital Management's Bio-Techne position peaked at $2.72M in Q1 2025.
  • 556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Polen Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.